Analysis of BLyS-dependent signatures and biology in the intestinal mucosa of patients with inflammatory bowel disease

Study identification

• EU PAS number:
  EUPAS46820
• Study ID:
  46821
• Official title and acronym:
  Analysis of BLyS-dependent signatures and biology in the intestinal mucosa of patients with inflammatory bowel disease
• DARWIN EU® study:
  No
• Study countries:
  Spain
• Study description:
  No information provided.
• Study status:
  Finalised

Study timelines

Date when funding contract was signed

Actual:17/02/2020

Study start date

Actual:18/02/2020

Date of final study report

Actual:29/03/2022

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

GlaxoSmithKlein Research and Development Limited

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable